Researchers at Emory think that genetic “bait and switch” could make their drug an effective treatment for the 2019 novel coronavirus (2019-nCoV) and COVID-19, the recently-minted name for the disease the viruses causes. “It’s a very simple principle: no virus, no disease,” George Painter, president of the Emory Institute for Drug Development, says. “Or [EIDD 2801] limits the amount of virus on board to a level that’s not sufficient to cause clinical signs and symptoms.”

Read the full article:
WABE